AlphaStocks
6.0
Consider Buy

Revvity, Inc. (RVTY)

As of Sep 20, 2026, Revvity, Inc. (RVTY) scores 6.0/10 on AlphaStocks' five-model composite, #52 of 168 Health Care stocks. At $143, RVTY trades 60% above its model fair value of $89.

Health Care / Health Care Equipment

S&P 500

$143.40

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#52out of 168 in Health Care

Is REVVITY, INC. a Good Investment in 2026?

REVVITY, INC. (RVTY) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates REVVITY, INC. as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 2.3% · ROC 26%. REVVITY, INC. currently trades 60% above its estimated fair value of $89. REVVITY, INC. ranks #52 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E69.3ROE3.3Market Cap16B

Estimated Fair Value

$89.4060% above

Trading above estimated fair value. P/e of 69x implies high growth expectations. eps growth of -6% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Stalwart

Greenblatt

Caution

Earnings yield 2.3% · ROC 26%

Frequently Asked Questions

Is REVVITY, INC. (RVTY) a good investment?
As of Sep 20, 2026, Revvity, Inc. (RVTY) scores 6.0/10 on AlphaStocks' five-model composite, #52 of 168 Health Care stocks. At $143, RVTY trades 60% above its model fair value of $89. That is a middle-of-the-pack score with no strong signal either way.
What is REVVITY, INC.'s Piotroski F-Score?
REVVITY, INC.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is RVTY overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $89, RVTY appears overvalued. The stock currently trades 60% above its estimated fair value. Trading above estimated fair value. P/e of 69x implies high growth expectations. eps growth of -6% may not justify the premium.
How does RVTY compare to other Health Care stocks?
REVVITY, INC. ranks #52 out of 168 stocks in the Health Care sector, placing it in the top 31% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about RVTY?
AlphaStocks evaluates RVTY using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 6.0/10.

Similar Stocks

Compare RVTY with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer